Interactions of SARS-CoV-2 with the Blood–Brain Barrier
Взаимодействие SARS-CoV-2 с гематоэнцефалическим барьером
2021-03-06
SCID: 54.1/b39wxkwv
Discuss with AI
SARS-CoV-2blood-brain barriercytokine stormneurological complicationsviral entry into the brain
Figures from the paper
Abstract (AI)
Emerging data indicate that neurological complications occur as a consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The blood-brain barrier (BBB) is a critical interface that regulates entry of circulating molecules into the CNS, and is regulated by signals that arise from the brain and blood compartments. In this review, we discuss mechanisms by which SARS-CoV-2 interactions with the BBB may contribute to neurological dysfunction associated with coronavirus disease of 2019 (COVID-19), which is caused by SARS-CoV-2. We consider aspects of peripheral disease, such as hypoxia and systemic inflammatory response syndrome/cytokine storm, as well as CNS infection and mechanisms of viral entry into the brain. We also discuss the contribution of risk factors for developing severe COVID-19 to BBB dysfunction that could increase viral entry or otherwise damage the brain.
Key Findings
1
Central nervous system infection and mechanisms of viral entry into the brain are potential pathways underlying SARS-CoV-2-related neurological complications.
2
Peripheral disease processes, including hypoxia and systemic inflammatory response syndrome or cytokine storm, may disrupt BBB function during COVID-19.
3
Risk factors for severe COVID-19 may promote BBB dysfunction, potentially increasing viral entry into the brain or causing additional neural damage.
4
SARS-CoV-2 interactions with the blood–brain barrier may contribute to neurological dysfunction associated with severe COVID-19.
5
The review integrates peripheral inflammation, hypoxia, CNS infection, and BBB regulation to explain how COVID-19 may affect the brain.
Research Object
Interactions of SARS-CoV-2 with the blood–brain barrier
Research Subject
Mechanisms by which SARS-CoV-2, peripheral disease factors, CNS infection, and severe-COVID-19 risk factors affect BBB integrity and viral entry into the brain, contributing to neurological dysfunction
Publication Details
Publication Date
2021-03-06
Journal
Publisher
ISSN
Cited by
151
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai9
A pneumonia outbreak associated with a new coronavirus of probable bat origin2020
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis2004
Coronavirus envelope protein: current knowledge2019
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients2020
Neurological associations of COVID-192020
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia2020
Neuroinvasion of SARS-CoV-2 in human and mouse brain2020
Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)2020
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier2020